Binnion P F, Murtagh G, Pollock A M, Fletcher E
Br Med J. 1969 Aug 16;3(5667):390-2. doi: 10.1136/bmj.3.5667.390.
Intravenous lignocaine (1 mg./kg. body weight) was found to produce insignificant haemodynamic changes, and in particular no reduction in myocardial contractility. A rate of 2 mg./minute infused intravenously is suggested for therapeutic purposes.In anaesthetized dogs an infusion of 13.5 mg./minute caused moderate haemodynamic depression and a maximum plasma level of 7 mug./ml. Massive injections of 200 and 400 mg. of lignocaine produced a maximum plasma level of 13.8 and 27.8 mug./ml., respectively, and in the latter failure of myocardial contraction in the presence of a normal E.C.G. ensued ("pump failure"). Lignocaine appears to alter the uptake of calcium by myocardial sarcoplasmic reticulum, and this may explain the negative inotropic effect of large doses.
静脉注射利多卡因(1毫克/千克体重)被发现会产生不显著的血流动力学变化,尤其是不会降低心肌收缩力。建议用于治疗目的的静脉输注速率为2毫克/分钟。在麻醉犬中,以13.5毫克/分钟的速率输注会导致中度血流动力学抑制,血浆最高水平为7微克/毫升。大量注射200毫克和400毫克利多卡因分别产生的血浆最高水平为13.8微克/毫升和27.8微克/毫升,并且在后者中,心电图正常的情况下出现了心肌收缩衰竭(“泵衰竭”)。利多卡因似乎会改变心肌肌浆网对钙的摄取,这可能解释了大剂量时的负性肌力作用。